Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) announced that the financial results for its first quarter of fiscal 2022, ending July 3, 2021, are now available on its Investor Relations website. A conference call is scheduled for August 11, 2021, at 8:00 a.m. ET to discuss these results, with access details provided. The company emphasized its commitment to improving patient care through innovative medical solutions. Further information is accessible via their investor portal.

BOSTON, Aug. 11, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2022, which ended July 3, 2021, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 11, 2021. The conference call and webcast can be accessed with the following information:

• U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
• Conference ID required for access: 1674067
• A live webcast of the call can be accessed on Haemonetics' Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/i5w7z4hk

In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.  

Direct link to 1Q FY22 Earnings Release:
https://haemonetics.gcs-web.com/static-files/ae3b0356-e98b-45b5-95da-300a335114d7

Direct link to 1Q FY22 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/7aef5a76-0b37-40ea-91ce-d6b0592279ea

A replay of the conference call and webcast will be available for one year beginning on August 11, 2021 at 11:00 a.m. ET using the conference call webcast link provided in this press release.

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact	Media Contact
Olga Guyette, Director-Investor Relations	Josh Gitelson, Director-Global Communications
(781) 356-9763	(781) 356-9776
olga.guyette@haemonetics.com	josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website-301352522.html

SOURCE Haemonetics Corporation

FAQ

What were Haemonetics' financial results for Q1 FY22?

The financial results for Haemonetics' first quarter of fiscal 2022 are detailed on their Investor Relations website.

When is the conference call for Haemonetics Q1 FY22 earnings?

The conference call is scheduled for August 11, 2021, at 8:00 a.m. ET.

How can I access Haemonetics Q1 FY22 earnings release?

You can access the Q1 FY22 earnings release directly on Haemonetics' Investor Relations website.

What is the conference ID for Haemonetics' earnings call?

The conference ID required for access to the earnings call is 1674067.